A detailed history of Cetera Investment Advisers transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 10,103 shares of CRL stock, worth $1.98 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,103
Previous 9,969 1.34%
Holding current value
$1.98 Million
Previous $2.06 Million 3.35%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$187.96 - $245.29 $25,186 - $32,868
134 Added 1.34%
10,103 $1.99 Million
Q2 2024

Aug 22, 2024

BUY
$206.39 - $268.73 $47,263 - $61,539
229 Added 2.35%
9,969 $2.06 Million
Q1 2024

May 24, 2024

BUY
$203.52 - $273.43 $1.82 Million - $2.44 Million
8,934 Added 1108.44%
9,740 $2.64 Million
Q1 2024

May 14, 2024

SELL
$203.52 - $273.43 $448,965 - $603,186
-2,206 Reduced 73.24%
806 $218,000
Q4 2023

Feb 13, 2024

BUY
$164.52 - $238.84 $33,233 - $48,245
202 Added 7.19%
3,012 $712,000
Q3 2023

Nov 14, 2023

BUY
$194.44 - $217.61 $3,499 - $3,916
18 Added 0.64%
2,810 $550,000
Q2 2023

Aug 09, 2023

BUY
$183.71 - $210.25 $182,424 - $208,778
993 Added 55.2%
2,792 $587,000
Q1 2023

May 15, 2023

SELL
$191.89 - $259.92 $15,543 - $21,053
-81 Reduced 4.31%
1,799 $363,000
Q4 2022

Feb 14, 2023

BUY
$197.11 - $250.07 $101,905 - $129,286
517 Added 37.93%
1,880 $409,000
Q3 2022

Nov 10, 2022

SELL
$182.44 - $250.54 $20,980 - $28,812
-115 Reduced 7.78%
1,363 $268,000
Q2 2022

Aug 11, 2022

BUY
$204.13 - $302.4 $11,635 - $17,236
57 Added 4.01%
1,478 $316,000
Q1 2022

May 13, 2022

SELL
$255.51 - $362.11 $309,678 - $438,877
-1,212 Reduced 46.03%
1,421 $404,000
Q4 2021

Feb 14, 2022

SELL
$351.38 - $448.68 $76,952 - $98,260
-219 Reduced 7.68%
2,633 $992,000
Q3 2021

Nov 16, 2021

SELL
$372.64 - $458.3 $7,825 - $9,624
-21 Reduced 0.73%
2,852 $1.18 Million
Q2 2021

Aug 13, 2021

BUY
$294.17 - $371.65 $317,997 - $401,753
1,081 Added 60.32%
2,873 $1.06 Million
Q1 2021

May 17, 2021

BUY
$249.67 - $299.48 $15,729 - $18,867
63 Added 3.64%
1,792 $519,000
Q4 2020

Feb 17, 2021

BUY
$222.0 - $252.62 $383,838 - $436,779
1,729 New
1,729 $432,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.96B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.